&lt;i&gt;NOTCH1&lt;/i&gt; Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 Trial
BeiGene
Zhihao Lu; Wenting Du; Xi Jiao; Yanni Wang; Jingwen Shi; Yang Shi; Yongqian Shu; Zuoxing Niu; Hiroki Hara; Jun Wu; Chih-Hung Hsu; Eric Van Cutsem; Malcolm V Brock; Zhang Zhang; Ningning Ding; Yun Zhang; Zhirong Shen; Lin Shen
Statistics, BeiGene (Beijing) Co, Ltd, Beijing, China.